scispace - formally typeset
P

Philippe Berny

Researcher at University of Lyon

Publications -  111
Citations -  3357

Philippe Berny is an academic researcher from University of Lyon. The author has contributed to research in topics: Population & Bromadiolone. The author has an hindex of 32, co-authored 98 publications receiving 2702 citations. Previous affiliations of Philippe Berny include École Normale Supérieure & Institut national de la recherche agronomique.

Papers
More filters
Journal ArticleDOI

Embedded lead shots in birds of prey: the hidden threat

TL;DR: Birds of prey with embedded lead have a mean blood level higher than the threshold of 200 μg/L defining the risk of subclinical effect occurrences and 60% of the lead-exposed birds had blood lead concentrations above the threshold, suggesting that embedded lead projectile may release lead and induce some long-term detrimental effects.
Journal ArticleDOI

Statement on the active substance acetamiprid

TL;DR: In this paper , the EFSA PPR Panel evaluated the likelihood of these studies indicating new or higher hazards and exposure to humans and the environment compared to previous EU assessments, and recommended conducting an assessment of endocrine disrupting properties for acetamiprid in line with EFSA/ECHA guidance document for the identification of the endocrine disruptors.
Journal ArticleDOI

A review of constraints and solutions for collecting raptor samples and contextual data for a European Raptor Biomonitoring Facility.

TL;DR: In this paper, the authors carried out a comprehensive review of the constraints that may limit the gathering in the field of raptor samples and contextual data, and assess their relative importance across Europe.
Journal ArticleDOI

Statement on the active substance flupyradifurone

TL;DR: The EFSA PPR Panel evaluated the likelihood of these studies indicating new or higher hazards and exposure to humans and the environment compared to previous EU assessments as discussed by the authors , and concluded that the new studies did not provide sufficient information to overrule the EU assessment, as in vivo studies already addressed the genotoxic potential of flupyradifurone.